SFP
NVCR icon

Sterling Financial Planning’s NovoCure NVCR Stock Holding History

Sterling Financial Planning’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-150
Closed -$17K – 289
2021
Q3 		$17K Hold
150
– – 0.01% 277
2021
Q2 		$33K Hold
150
– – 0.02% 210
2021
Q1 		$20K Hold
150
– – 0.01% 226
2020
Q4 		$26K Buy
+150
New +$20.5K 0.02% 192

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sterling Financial Planning's NVCR Position: Q4 2021 in Review

Sterling Financial Planning sold out of NovoCure (NVCR) in Q4 2021, closing a stake of 150 shares — an estimated $17K sold.

Sterling Financial Planning first reported a position in NVCR in Q4 2020 and held it in 4 quarters. The position peaked at $33K in Q2 2021. 311 funds tracked by Wall St. Rank hold NVCR as of Q4 2021.

  • Sterling Financial Planning reported no remaining NovoCure position as of Q4 2021 after selling out during the quarter.
  • Sterling Financial Planning sold 150 NovoCure shares in Q4 2021, an estimated $17K.
  • Sterling Financial Planning first reported a position in NovoCure in Q4 2020 and held it in 4 quarters.
  • Sterling Financial Planning's NovoCure position peaked at $33K in Q2 2021.
  • 311 funds tracked by Wall St. Rank held NovoCure as of Q4 2021.

Based on Sterling Financial Planning's 13F filing for Q4 2021, filed 2 Feb 2022.